Desenvolvida como um agonista de mltiplos receptores hormonais, a retatrutida atua simultaneamente nos receptores de GLP-1, GIP e glucagon, oferecendo uma abordagem inovadora no tratamento da obesidade
GLP-1 therapies are shaking up the world of diabetes and obesity care, opening new doors for both patients and pharmaceutical companies
Glutamine-induced secretion of intestinal secretory immunoglobulin a: a mechanistic perspective
Wen J., Nadora D., Bernstein E., et al., Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP1 Receptor Agonists: A Systematic Review and MetaAnalysis of Randomised Controlled Trials, Endocrinology, Diabetes & Metabolism 8, no
And while its always best to get these nutrients from food, supplements can help fill in the gaps, especially when your appetite is tamped down